Increased retinal blood flow in patients with active graves' ophthalmopathy

Current Eye Research

Volumn 32, Issue 11, 2007, Pages 985-990

  Perri, Paolo ^a   Campa, Claudio ^a   Costagliola, Ciro ^a   Incorvaia, Carlo ^a   D'Angelo, Sergio ^a   Sebastiani, Adolfo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Graves' ophthalmopathy; Heidelberg retina flowmeter; Retinal blood flow

Indexed keywords

A SCAN; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE EXAMINATION; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; PRIORITY JOURNAL; RETINA BLOOD FLOW; VISUAL FIELD;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FEMALE; GRAVES OPHTHALMOPATHY; HEART RATE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; PERIMETRY; REGIONAL BLOOD FLOW; RETINAL VESSELS; VISUAL FIELDS;

EID: 36249015564     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701689773     Document Type: Article

References (26)

1. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-835.
2. Alimgil ML, Benian O, Esgin H, Erda S. Ocular pulse amplitude in patients with Graves' disease: a preliminary study. Acta Ophthalmol Scand. 1999;77:694-696.
3. Alp MN, Ozgen A, Can I, Cakar P, Gunalp I. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation. Br J Ophthalmol. 2000;84:1027-1030.
4. Benning H, Lieb W, Kahaly G, Grehn F. Color duplex ultrasound findings in patients with endocrine orbitopathy. Ophthalmologe. 1994;91:20-25.
5. Hartmann K, Meyer-Schwickerath R. Measurement of venous outflow pressure in the central retinal vein to evaluate intraorbital pressure in Graves' ophthalmopathy: a preliminary report. Strabismus. 2000;8:187-193.
6. Kurioka Y, Inaba M, Kawagishi T, Emoto M, Kumeda Y, Inoue Y, et al. Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy. Eur J Endocrinol. 2001;144:99-107.
7. Li H, Liu YH, Li DH, Zhang Y. Value of measurements of blood flow velocity in central retinal artery in thyroid-associated ophthalmopathy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;26:460-462.
8. Tsai CC, Kau HC, Kao SC, Lin MW, Hsu WM, Liu JH, Wei YH. Pulsatile ocular blood flow in patients with Graves ophthalmopathy. Eye. 2005;19:159-162.
9. Somer D, Ozkan SB, Ozdemir H, Atilla S, Soylev MF, Duman S. Colour Doppler imaging of superior ophthalmic vein in thyroid-associated eye disease. Jpn J Ophthalmol. 2002;46:341-345.
10. Logan JF, Rankin SJ, Jackson AJ. Retinal blood flow measurements and neuroretinal rim damage in glaucoma. Br J Ophthalmol. 2004;88:1049-1054.
11. Remsch H, Spraul CW, Lang GK, Lang GE. Changes of retinal capillary blood flow in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol. 2000;238:960-964.
12. Cuypers MH, Kasanardjo JS, Polak BC. Retinal blood flow changes in diabetic retinopathy measured with the Heidelberg scanning laser Doppler flowmeter. Graefes Arch Clin Exp Ophthalmol. 2000;238:935-941.
13. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol. 1995;120:511-517.
14. Prummel MF, Suttorp-Schulten MS, Wiersinga WM, Verbeek AM, Mourits MP, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology. 1993;100:556-561.
15. Ossoinig KC. The role of standardized ophthalmic ecography in the management of Graves' ophthalmopathy. Dev Ophthalmol. 1989;20:28-37.
16. Michelson G, Welzenbach J, Pal I, Harazny J. Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol. 1998;82:1294-1300.
17. Hochberg, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75:800-803.
18. Klein I. Thyroid hormone and the cardiovascular system. American Journal of Medicine. 1990;88:631-637.
19. Morikawa Y, Morikawa A, Makino I. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones. J Clin Endocrinol Metab. 1993;76:609-614.
20. Donnini D, Ambesi-Impiombato FS, Curcio F. Thyrotropin stimulates production of procoagulant and vasodilative factors in human aortic endothelial cells. Thyroid. 2003;13:517-521.
21. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res. 2000;32:249-256.
22. Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, Graeb D. Graves' orbitopathy: correlation of CT and clinical findings. Radiology. 1990;177: 675-682.
23. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369:425-435.
24. Kikkawa DO, Cruz RC Jr, Christian WK, Rikkers S, Weinreb RN, Levi L, Granet DB. Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure. Am J Ophthalmol. 2003;135:427-431.
25. Ohtsuka K. Intraocular pressure and proptosis in 95 patients with Graves' ophthalmopathy. Am J Ophthalmol. 1997;124:570-572.
26. Ludgate M, Baker G. Inducing Graves' ophthalmopathy. J Endocrinol Invest. 2004;27:211-215.